Log in | Register

Large Format Folder Accommmodates FDA Requirement For Increased Type In Inserts

For the latest pharmaceutical news and updates - Sign up now!
Loading...
Large Format Folder Accommmodates FDA Requirement For Increased Type In Inserts

Company has installed a Vijuk MV large format folder in its Evansville, IN facility. This purchase is in response to the FDA requirement for larger font sizes and additional prescribing information (RTA large format) on packaging inserts to manage the risk of medical product use and reduce medication errors. The increased type size necessitates the need for larger inserts. It’s a challenge for many drug companies to meet this requirement without having to make major changes to their existing packaging lines. The folder can fold inserts up to 150 panels thick, whereas many industry folding machines can only fold 90 to 120 panels. It can fold a flat sheet of up to 20.75 inches wide and can produce folded inserts that are smaller and thicker than other folders. The folder has a folding rate speed at 150% of many other folders and stores job settings for quicker make-readies. It also features an upgraded glue system and a digital water score system.

Cortegra, Fairfield, NJ 07004. www.cortegra.com or call 800-242-4657

INTERPHEX New York 2010 Booth No. 401

 

 

 

 

 

Register or log in to send e-mail for more info

E-mail to a colleague

See company's other products

Cortegra Group Inc.
6 Commerce Road
Fairfield, NJ, 07004
Phone: 973-808-8000
Fax: 973-808-8010
Join the Discussion
Rate Article:  Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Blogs

The Tale of Two Deviations

The Tale of Two Deviations

Apr 23 | The QA Pharm

It stands to reason that pharmaceutical companies in compliance trouble also have problems with their Deviation Management and Corrective and Preventive Action (CAPA) System(s).

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Apr 16 | Girish Malhotra, PE, President, EPCOT International

The answer is an unequivocal yes but we need some outsiders who can conspire with the insiders who will be the flag bearers within the companies. Outsiders can be the counsels/co-conspirators to the insiders for the coup d'etat.

Multimedia

Lung Cancer Drug Treats Rare Lymphoma Tumors

Lung Cancer Drug Treats Rare Lymphoma Tumors

May 17 | Video

A new study found Xalkori effective in treating anaplastic lymphoma among children, an encouraging development for gene-targeted therapy.

Merck - 2012 Facility of the Year Award - Facility Integration

Merck - 2012 Facility of the Year Award - Facility Integration

May 14 | Video

Brian Morrissey, Senior Project Engineer, Merck Manufacturing Division, talks to Pharmaceutical Processing's Editor In Chief Mike Auerbach during INTERPHEX 2012 about the company's Vaccine Bulk Manufacturing Facility Program of Projects. The facility has won the Facility Integration award in the 2012 Facility of the Year Award competition sponsored by ISPE, INTERPHEX and Pharmaceutical Processing magazine.

Medicine from a Vending Machine?

Medicine from a Vending Machine?

May 3 | Video

A Chinese company is pushing for acceptance of traditional Chinese medicine with a machine that can dispense herbs.

Taking Precautions to Prevent Contagion

Taking Precautions to Prevent Contagion

Apr 29 | Video

With the recent outbreak of viruses such as SARS, bird flu and swine flu, officials and travelers are being extra careful about preventing the illnesses from being transmitted.

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter